Abstract

A “restrictive” red blood cell transfusion threshold, a hemoglobin concentration <7 to 8 g/dL, has long been recommended for most hospitalized patients including anemic patients with stable cardiovascular disease (CVD). Although no threshold recommendation is given for acute coronary syndromes (ACSs), recent evidence suggests that “liberal” rather than “restrictive” transfusion strategies are associated with significantly improved safety for hospitalized patients with stable CVD and/or ACS. This finding suggests that previously available data were misinterpreted. Conclusions drawn from earlier transfusion trigger trials have been confounded by unintentional trial design and analysis flaws that have contributed to erroneous recommendations regarding the safety of a restrictive threshold. Subsequently, these conclusions have been incorporated into widely accepted guidelines and clinical practice. Management with a restrictive vs liberal transfusion strategy (<10 g/dL) increases the risk of new-onset ACS in patients with CVD by ∼2%. We estimate that since 2019, using hospital databases and a recent meta-analysis, this practice may have resulted in ∼700 excess ACS events per year in orthopedic surgical patients. Given these findings, transfusion practices in other clinical conditions, particularly those derived from similar transfusion trigger trials, should be questioned. Restrictive and liberal transfusion policies merit a general reconsideration. Rather than a single numerical transfusion trigger, transfusion therapy should be personalized. Consideration of an individual patient’s age, clinical status, and comorbidities is integral to transfusing. To avoid making similar errors, future trials of transfusion therapy should determine common practices before study inception and incorporate them as a usual-care “control” comparator arm into the trial design. Such studies should more reliably improve current transfusion practice.

1.
Sabatine
MS
,
Morrow
DA
,
Giugliano
RP
, et al
.
Association of hemoglobin levels with clinical outcomes in acute coronary syndromes
.
Circulation
.
2005
;
111
(
16
):
2042
-
2049
.
2.
Carson
JL
,
Duff
A
,
Poses
RM
, et al
.
Effect of anaemia and cardiovascular disease on surgical mortality and morbidity
.
Lancet
.
1996
;
348
(
9034
):
1055
-
1060
.
3.
Wu
WC
,
Rathore
SS
,
Wang
Y
,
Radford
MJ
,
Krumholz
HM
.
Blood transfusion in elderly patients with acute myocardial infarction
.
N Engl J Med
.
2001
;
345
(
17
):
1230
-
1236
.
4.
Wang
JK
,
Klein
HG
.
Red blood cell transfusion in the treatment and management of anaemia: the search for the elusive transfusion trigger
.
Vox Sang
.
2010
;
98
(
1
):
2
-
11
.
5.
Hébert
PC
,
Wells
G
,
Tweeddale
M
, et al
.
Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group
.
Am J Respir Crit Care Med
.
1997
;
155
(
5
):
1618
-
1623
.
6.
Yang
X
,
Alexander
KP
,
Chen
AY
, et al
.
The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative
.
J Am Coll Cardiol
.
2005
;
46
(
8
):
1490
-
1495
.
7.
Hébert
PC
,
Yetisir
E
,
Martin
C
, et al
.
Is a low transfusion threshold safe in critically ill patients with cardiovascular disease?
.
Crit Care Med
.
2001
;
29
(
2
):
227
-
234
.
8.
Alexander
KP
,
Chen
AY
,
Wang
TY
, et al
.
Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes
.
Am Heart J
.
2008
;
155
(
6
):
1047
-
1053
.
9.
Murphy
MF
,
Wallington
TB
,
Kelsey
P
, et al
.
Guidelines for the clinical use of red cell transfusions
.
Br J Haematol
.
2001
;
113
(
1
):
24
-
31
.
10.
Carson
JL
,
Grossman
BJ
,
Kleinman
S
, et al
.
Red blood cell transfusion: a clinical practice guideline from the AABB
.
Ann Intern Med
.
2012
;
157
(
1
):
49
-
58
.
11.
Carson
JL
,
Stanworth
SJ
,
Dennis
JA
, et al
.
Transfusion thresholds for guiding red blood cell transfusion
.
Cochrane Database Syst Rev
.
2021
;
12
(
12
):
CD002042
.
12.
Ducrocq
G
,
Gonzalez-Juanatey
JR
,
Puymirat
E
, et al
.
Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial
.
JAMA
.
2021
;
325
(
6
):
552
-
560
.
13.
Gonzalez-Juanatey
JR
,
Lemesle
G
,
Puymirat
E
, et al
.
One-year major cardiovascular events after restrictive versus liberal blood transfusion strategy in patients with acute myocardial infarction and anemia: the REALITY randomized trial
.
Circulation
.
2022
;
145
(
6
):
486
-
488
.
14.
Carson
JL
,
Brooks
MM
,
Hébert
PC
, et al
.
Restrictive or liberal transfusion strategy in myocardial infarction and anemia
.
N Engl J Med
.
2023
;
389
(
26
):
2446
-
2456
.
15.
Applefeld
WN
,
Ford
V
,
Cortés-Puch
I
, et al
.
Risks of restrictive versus liberal red blood cell transfusion strategies in patients with cardiovascular disease: an updated meta-analysis
.
Circ Cardiovasc Qual Outcomes
.
2024
;
17
(
6
):
e010957
.
16.
Premier Healthcare Database White Paper: Data that informs and performs, September 7, 2020. Premier Applied Sciences®. Premier Inc
. Accessed 20 April 2024. https://offers.premierinc.com/rs/381-NBB-525/images/PremierHealthcareDatabaseWhitepaper.pdf.
17.
Hébert
PC
,
Wells
G
,
Blajchman
MA
, et al
.
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group
.
N Engl J Med
.
1999
;
340
(
6
):
409
-
417
.
18.
Consensus conference: Perioperative red blood cell transfusion
.
JAMA
.
1988
;
260
:
2700
-
2703
.
19.
Practice strategies for elective red blood cell transfusion. American College of Physicians
.
Ann Intern Med
.
1992
;
116
(
5
):
403
-
406
.
20.
Hebert
PC
,
Wells
G
,
Martin
C
, et al
.
A Canadian survey of transfusion practices in critically ill patients
.
Crit Care Med
.
1998
;
26
(
3
):
482
-
487
.
21.
Deans
KJ
,
Minneci
PC
,
Suffredini
AF
, et al
.
Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols
.
Crit Care Med
.
2007
;
35
(
6
):
1509
-
1516
.
22.
Macklin
R
,
Natanson
C
.
Misrepresenting “usual care” in research: an ethical and scientific error
.
Am J Bioeth
.
2020
;
20
(
1
):
31
-
39
.
23.
Ford
VJ
,
Klein
HG
,
Danner
RL
, et al
.
Controls, comparator arms, and designs for critical care comparative effectiveness research: it’s complicated
.
Clin Trials
.
2024
;
21
(
1
):
124
-
135
.
24.
Applefeld
WN
,
Wang
J
,
Cortés-Puch
I
, et al
.
Modeling current practices in critical care comparative effectiveness research
.
Crit Care Resusc
.
2022
;
24
(
2
):
150
-
162
.
25.
Cortés-Puch
I
,
Wiley
BM
,
Sun
J
, et al
.
Risks of restrictive red blood cell transfusion strategies in patients with cardiovascular disease (CVD): a meta-analysis
.
Transfus Med
.
2018
;
28
(
5
):
335
-
345
.
26.
Carson
JL
,
Terrin
ML
,
Noveck
H
, et al
.
Liberal or restrictive transfusion in high-risk patients after hip surgery
.
N Engl J Med
.
2011
;
365
(
26
):
2453
-
2462
.
27.
Adams
RC
,
Lundy
JS
.
Anesthesia in cases of poor risk. Some suggestions for decreasing the risk
.
Surg Gynecol Obstet
.
1942
;
74
:
1011
-
1101
.
28.
Gregersen
M
,
Borris
LC
,
Damsgaard
EM
.
Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial
.
Acta Orthop
.
2015
;
86
(
3
):
363
-
372
.
29.
Robitaille
N
,
Lacroix
J
,
Alexandrov
L
, et al
.
Excess of veno-occlusive disease in a randomized trial on a higher trigger for red cell transfusion after bone marrow transplantation: a Canadian blood and marrow transplant group trial
.
Biol Blood Marrow Transplant
.
2013
;
19
(
3
):
468
-
473
.
30.
Webert
KE
,
Cook
RJ
,
Couban
S
, et al
.
A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation
.
Transfusion
.
2008
;
48
(
1
):
81
-
91
.
31.
Yakymenko
D
,
Frandsen
KB
,
Christensen
IJ
, et al
.
Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapy
.
Transfus Med
.
2018
;
28
(
3
):
208
-
215
.
32.
Hoff
CM
,
Hansen
HS
,
Overgaard
M
, et al
.
The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy–results from the randomized DAHANCA 5 study
.
Radiother Oncol
.
2011
;
98
(
1
):
28
-
33
.
33.
Chow
JH
,
Mazzeffi
MA
,
Tanaka
KA
.
Teaching an old dog new TRICS: re-evaluating transfusion triggers in high-risk cardiac surgery
.
J Thorac Dis
.
2018
;
10
(
2
):
674
-
677
.
34.
Friedman
BA
,
Burns
TL
,
Schork
MA
.
An analysis of blood transfusion of surgical patients by sex: a question for the transfusion trigger
.
Transfusion
.
1980
;
20
(
2
):
179
-
188
.
35.
Vincent
JL
,
Baron
J-F
,
Reinhart
K
, et al
.
Anemia and blood transfusion in critically ill patients
.
JAMA
.
2002
;
288
(
12
):
1499
-
1507
.
36.
Corwin
HL
,
Gettinger
A
,
Pearl
RG
, et al
.
The CRIT study: anemia and blood transfusion in the critically ill–current clinical practice in the United States
.
Crit Care Med
.
2004
;
32
(
1
):
39
-
52
.
37.
Vuille-Lessard
E
,
Boudreault
D
,
Girard
F
,
Ruel
M
,
Chagnon
M
,
Hardy
JF
.
Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study
.
Transfusion
.
2010
;
50
(
10
):
2117
-
2124
.
38.
Carson
JL
,
Stanworth
SJ
,
Guyatt
G
, et al
.
Red blood cell transfusion: 2023 AABB International Guidelines
.
JAMA
.
2023
;
330
(
19
):
1892
-
1902
.
39.
Mueller
MM
,
Van Remoortel
H
,
Meybohm
P
, et al
.
Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference; ICC PBM Frankfurt 2018 Group
.
JAMA
.
2019
;
12
(
10
):
983
-
997
.
40.
Turgeon
AF
,
Fergusson
DA
,
Clayton
L
, et al
.
Liberal or restrictive transfusion strategy in patients with traumatic brain injury
.
N Engl J Med
.
2024
.
41.
Radford
M
,
Estcourt
LJ
,
Sirotich
E
, et al
.
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support
.
Cochrane Database Syst Rev
.
2024
;
5
(
5
):
CD011305
.
42.
Klein
HG
,
Flegel
WA
,
Natanson
C
.
Red blood cell transfusion: precision vs imprecision medicine
.
JAMA
.
2015
;
314
(
15
):
1557
-
1558
.
43.
Neal
MD
,
Hunt
BJ
.
Precision in transfusion medicine
.
JAMA
.
2023
;
330
(
19
):
1847
-
1848
.
44.
Montemayor
C
,
Brunker
PAR
,
Keller
MA
.
Banking with precision: transfusion medicine as a potential universal application in clinical genomics
.
Curr Opin Hematol
.
2019
;
26
(
6
):
480
-
487
.
45.
Roubinian
NH
,
Reese
SE
,
Qiao
H
, et al
.
Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness
.
JCI Insight
.
2022
;
7
(
1
):
e152598
.
46.
Thau
MR
,
Liu
T
,
Sathe
NA
, et al
.
Association of trauma molecular endotypes with differential response to transfusion resuscitation strategies
.
JAMA Surg
.
2023
;
158
(
7
):
728
-
736
.
47.
Wu
J
,
Vodovotz
Y
,
Abdelhamid
S
, et al;
PAMPer Study Group
.
Multi-omic analysis in injured humans: patterns align with outcomes and treatment responses
.
Cell Rep Med
.
2021
;
2
(
12
):
100478
.
You do not currently have access to this content.
Sign in via your Institution